Association Between Dose Dialysis by Kt and Mortality

N

NephroCare

Status

Completed

Conditions

Hemodialysis Patients
End Stage Renal Disease

Study type

Observational

Funder types

Industry

Identifiers

NCT01932853
QM-RR-02

Details and patient eligibility

About

The aim of this study is to assess whether patients receiving current recommendations of an adequate dialysis dose by Kt adjusted for body surface area improved survival at 24 months compared to those who do not get it, as well as assess whether patients receiving a dose greater obtain more benefit.

Enrollment

6,129 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • > 18 years old
  • > six months on hemodialysis
  • Receiving 3 sessions of dialysis per week
  • Having 5 or more valid measures of Kt during the month

Exclusion criteria

  • active chronic inflammatory diseases
  • Liver cirrhosis
  • Neoplasms
  • Chronic immunosuppression or use of anti-inflammatory

Trial design

6,129 participants in 1 patient group

Hemodialysis patients
Description:
Patients > 18y hemodialysis for at least 6 months at any center of Spain Fresenius Medical Care (FMC) meeting the inclusion criteria.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems